This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Health and Medical Research. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: Andre C De Paulet: Innovator in Immunoenzymatic Assays
Introduction
Andre C De Paulet is a notable inventor based in Montpellier, France. He has made significant contributions to the field of immunoenzymatic assays, particularly through his innovative methods that enhance the detection of low-concentration substances.
Latest Patents
Andre C De Paulet holds a patent for a "Method of immunoenzymatic assay utilizing .DELTA..sub.5,3-keto-steroid." This invention introduces a novel enzymatic labeling agent for immunoenzymatic assays. The labeling agent, .DELTA..sub.5, 3-keto-steroid isomerase, allows for various advantageous reading methods. These include direct reading on supernatant liquor or precipitated cakes, reading in solution after enzyme liberation, and immediate reading after filtration of substrate solutions on the antibody-antigen-enzyme complex. This method is particularly useful for detecting substances present in very low concentrations, such as hypophysial hormones and plasmatic steroids.
Career Highlights
Andre C De Paulet is affiliated with the National Institute of Health and Medical Research, where he continues to advance research in immunoenzymatic assays. His work has been instrumental in developing techniques that improve the accuracy and efficiency of assays used in medical research.
Collaborations
He has collaborated with notable colleagues, including Beatrice Terouanne and Jean C Nicolas. Their combined expertise has contributed to the advancement of research in their field.
Conclusion
Andre C De Paulet's innovative work in immunoenzymatic assays exemplifies the impact of dedicated research on medical diagnostics. His contributions continue to influence the detection of critical biological substances.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
